Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1

Interventions

Cyclophosphamide 4 trastuzumab deruxtecan 3 fludarabine 3 Standard of Care 3 Injections 3 Cisplatin 3 Bevacizumab 3 toripalimab 2 sacituzumab govitecan 2 pembrolizumab 2 fludarabine phosphate 2 Specimen Handling 2 Radiosurgery 2 Pemetrexed 2 Palliative Care 2 Gemcitabine 2 Fulvestrant 2 Fluorouracil 2 Docetaxel 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vedolizumab 1 tislelizumab 1 sintilimab 1 lobaplatin 1 lenvatinib 1 ivosidenib 1 irinotecan sucrosofate 1 exemestane 1 eribulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Neoplasm Metastasis × Arsenic Trioxide × Clear all

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡